ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SNG Synairgen Plc

4.65
0.00 (0.00%)
Last Updated: 08:00:15
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.65 4.36 4.99 - 128,564 08:00:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.36M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.65p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.36 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 18251 to 18270 of 99175 messages
Chat Pages: Latest  739  738  737  736  735  734  733  732  731  730  729  728  Older
DateSubjectAuthorDiscuss
28/7/2020
10:18
Nortic

Think your right man tooth hurty.

simon_64
28/7/2020
10:14
DNL =3x Approvals expected during next 2 months including an Orphan Drug with FDA decision on September 29 = CHEAPEST UK Biotech a potential 500%++ GEM

Diurnal Group (DNL) = MCap £38 M / Cash £15 M or enough untill early 2022 / LOTS of BIG milestones on the way = Still the MOST attractive and CHEAPEST pharma stock in UK has potential to run toward 200p very fast especially on approval of Alkindi in USA (expected in September) and Chronocort in Europe (expected in Q1 ) =STRONG BUY AGGRESSIVE a sleeping giant here .GL

Market Cap £38 million
Cash £15 million
Price 30p


Alkindi approval in Australia expected this Quarter
Alkindi approval in Israel expected this Quarter
FDA decision for Alkindi on September 29
EMA Decision for Chronocort expected in early Q1 2021

ih_752952
28/7/2020
09:59
So our new investors have awesome credentials;
pointscorer
28/7/2020
09:52
Or just to generate a market
tricky red
28/7/2020
09:38
More like a snort of Charlie and a nip from the hip flask.
simon_64
28/7/2020
09:35
....or just to stifle trade so they can pop off and get a cuppa?
thamestrader
28/7/2020
09:30
A widespread is often used to try to stop buyers while they fill orders imho
little minx
28/7/2020
09:25
Spread all over the place...the offer is 216p
pointscorer
28/7/2020
09:21
Well at least they managed to rinse a few shares for our big buyer.

Onwards and upwards.

simon_64
28/7/2020
09:19
Fund for big Pharmaceutical
Bought after ride

Hold hold hold

michael boyle1
Chat Pages: Latest  739  738  737  736  735  734  733  732  731  730  729  728  Older

Your Recent History

Delayed Upgrade Clock